What Researchers Did
Researchers investigated how a small number of participants in a clinical trial for hyperbaric oxygen therapy for multiple sclerosis evaluated the treatment and decided whether to continue using it after the trial.
What They Found
While clinical trials showed no therapeutic benefit for hyperbaric oxygen therapy in multiple sclerosis, participants continued to use it. The study found that the clinical trial's assumptions about therapeutic benefit differed significantly from the participants' own evaluations and concepts of benefit.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study's findings are based on a small number of participants and may not be generalizable to all patients with multiple sclerosis or other therapies.